Purpose To present a case of struma ovarii with a typical features and synchronous primary
thyroid carcinoma and review the available literature to guide diagnosis and management of …

Aim To evaluate the clinico‐pathologic features, treatment options, prognostic factors, and
survival outcomes of malignant struma ovarii based on a systematic literature review in …

Introduction: Struma ovarii accounts for 2% of mature teratomas. Struma ovarii is diagnosed
when thyroid tissue accounts for> 50% of the teratoma. Malignant transformation is rare …

Objective. To present a rare case of malignant struma ovarii (MSO) and synchronous thyroid
cancer, review the medical literature, and present the latest trends in management. Methods …

Introduction. Struma ovarii (SO) is a monodermal teratoma in which thyroid tissue comprises
more than 50% of the tumour. Papillary thyroid cancer (PTC) in SO is a rare finding, as only …

Aim: To describe the case of a bilateral ovarian dysgerminoma treatment with 11-year follow-
up. Methods: Case report with details regarding clinical history, surgical treatment …

Struma ovarii is an infrequent type of teratoma arising from the ovary accounting for only 2%
of all ovarian teratomas. These tumors have a benign biology with rare malignant …

Conclusion: There is still no established treatment consensus for follicular carcinoma of SO
patients. The choice for a conservative or radical approach depends on the doctor. However …

Malignant germ cell tumors of the ovary (OGCTs) are rare and represented less than 5% of
all germ cell tumors of the ovary. GCTs are composed of several histological types and are …

Introducción: El struma ovarii comprende el 0.3% de las neoplasias ováricas. Presentación
de caso: Mujer de 46 años con antecedente de struma ovarii. Acude por presentar lesiones …